| abstract |
The present invention relates to a compound of formula (I), wherein the variables shown in formula (I) are as defined in the specification, having an inhibitory activity against sodium-dependent glucose transporter (SGLT) being present in the intestine or kidney of a mammalian species. The compound of formula (I) is useful in the manufacture of medicaments for the treatment of diabetes mellitus or diabetic complications such as diabetic retinopathy, diabetic neuropathy, diabetic nephropathy and delayed wound healing. |